Qu Biologics’ Phase 2 RESTORE trial data presented at 2021 European Crohn’s and Colitis Congress

Ads

You May Also Like

Biopharmaceutical Market Scope Rising With Escalating Health Concerns – IndustryARC

Hyderabad, India, March 27, 2017 (GLOBE NEWSWIRE) -- The report “Biopharmaceutical Market: By Source ...

2017 Men’s Health Month Reaches New

Washington, D.C., June 30, 2017 (GLOBE NEWSWIRE) -- After reaching millions of people through ...

Medigus to Begin Clinical Study in China for CFDA Regulatory Clearance

Medigus receives first purchase order from Golden Grand-Medical Instruments Ltd. to advance commercial agreement ...